BUSINESSCNBC TOP
U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns
The CEO of Indian pharma company Dr Reddy's warned that Trump's proposed tariffs on generic drugs will increase their prices in the U.S. for patients.
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and more
- What Trump's generic drug tariffs could mean, according to experts
- New Trump tariffs to block Indian, Chinese generic drugs sourcing
- Trump plans steep tariffs on generic drugs starting in 2028 to spur U.S. production